GB0904271D0 - Treatment of diabetes and metabolic syndrome - Google Patents
Treatment of diabetes and metabolic syndromeInfo
- Publication number
- GB0904271D0 GB0904271D0 GB0904271A GB0904271A GB0904271D0 GB 0904271 D0 GB0904271 D0 GB 0904271D0 GB 0904271 A GB0904271 A GB 0904271A GB 0904271 A GB0904271 A GB 0904271A GB 0904271 D0 GB0904271 D0 GB 0904271D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- diabetes
- treatment
- metabolic syndrome
- metabolic
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0904271A GB0904271D0 (en) | 2009-03-12 | 2009-03-12 | Treatment of diabetes and metabolic syndrome |
KR1020117023810A KR101673042B1 (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome |
EP10708193.7A EP2405934B1 (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome |
EP14159411.9A EP2762150A1 (en) | 2009-03-12 | 2010-03-10 | Treatment of Diabetes and Metabolic Syndrome |
CN201080011177.1A CN102369018B (en) | 2009-03-12 | 2010-03-10 | Diabetes and the treatment of metabolism syndrome |
AU2010223329A AU2010223329B2 (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome |
CA2755068A CA2755068C (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome |
BRPI1009392A BRPI1009392A2 (en) | 2009-03-12 | 2010-03-10 | "pharmaceutical formulation, and use of a pharmaceutically effective amount of a pharmaceutical formulation." |
JP2011553445A JP5993147B2 (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome |
MX2011009559A MX2011009559A (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome. |
NZ595021A NZ595021A (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome with enteral formulations of calcitonin peptides or calcitonin receptor agonists |
PCT/EP2010/053044 WO2010103045A1 (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome |
US13/255,854 US20120046224A1 (en) | 2009-03-12 | 2010-03-10 | Treatment of diabetes and metabolic syndrome |
RU2011141291/15A RU2537181C2 (en) | 2009-03-12 | 2010-03-10 | Treating diabetes and metabolic syndrome |
CL2011002229A CL2011002229A1 (en) | 2009-03-12 | 2011-09-09 | Pharmaceutical formulation comprising an active compound that is a member of the calcitonin family that is not amylin. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0904271A GB0904271D0 (en) | 2009-03-12 | 2009-03-12 | Treatment of diabetes and metabolic syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0904271D0 true GB0904271D0 (en) | 2009-04-22 |
Family
ID=40600933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0904271A Ceased GB0904271D0 (en) | 2009-03-12 | 2009-03-12 | Treatment of diabetes and metabolic syndrome |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0904271D0 (en) |
-
2009
- 2009-03-12 GB GB0904271A patent/GB0904271D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL259475A (en) | Combination therapy for the treatment of diabetes | |
IL210856A0 (en) | Combination therapy for the treatment of diabetes and related conditions | |
PL3181134T3 (en) | Bifidobacteria for treating diabetes and related conditions | |
GB2496799B (en) | A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders | |
SI2376077T1 (en) | Composition and method for treatment of diabetes | |
IL223289A0 (en) | Treatment of type 2 diabetes | |
EP2434010A4 (en) | Prophylactic and/or therapeutic agent for metabolic syndrome | |
EP2480246A4 (en) | Composition and method for treatment of diabetes | |
HK1169993A1 (en) | Hsl inhibitors useful in the treatment of diabetes hsl | |
PL2397151T3 (en) | Treatment of vascular complications of diabetes | |
EP2498810A4 (en) | Treatment of sleep disordered breathing with neurotoxin | |
HK1202819A1 (en) | Treatment of type i and type ii diabetes i ii | |
EP2437771A4 (en) | Compositions and methods modulating mg29 for the treatment of diabetes | |
EP2498794A4 (en) | Method of treatment of type 2 diabetes | |
GB0912906D0 (en) | Treatment of diabetes and metabolic syndrome | |
GB0910904D0 (en) | Treatment of diabetes and metabolic syndrome | |
GB0904271D0 (en) | Treatment of diabetes and metabolic syndrome | |
GB201003894D0 (en) | Inhibitors of glucose metabolism for use in the treatment of Birt-Hogg-Dubé syndrome | |
EP2598152A4 (en) | Treatment of metabolic syndrome and insulin resistance with citrus flavanones | |
EP2356986A4 (en) | Composition for treatment of metabolic syndrome | |
GB0802904D0 (en) | Treatment of metabolic syndrome | |
GB0802903D0 (en) | Treatment of diabetes | |
AU2009900265A0 (en) | Treatment of diabetes and other diseases | |
AU2010902914A0 (en) | Treatment of diabetes | |
GB201007977D0 (en) | Treatment of cardiovascular disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |